Entera Bio Ltd. — Director's Dealing 2025

May 20, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2025-05-08

Reporting Person: Gautam Leslie Velka (Chief Business Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$2.28	2035-04-28	Ordinary Shares, par value NIS 0.0000769 per share (60000)		Direct

Footnotes

F1: The options vest over a three-year period that commenced on April 28 2025, with one-third (1/3) of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining two-year period.